SCS Capital Management’s AGCO AGCO Stock Holding History

SCS Capital Management’s Portfolio AGCO Stock Details AGCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$239K	Hold	2,000	–	–	﹤0.01%	447
2026 Q1	$232K	Hold	2,000	–	–	﹤0.01%	437
2025 Q4	$209K	Hold	2,000	–	–	﹤0.01%	471
2025 Q3	$214K	Hold	2,000	–	–	﹤0.01%	487
2025 Q2	$206K	Buy	+2,000	New	+$191K	﹤0.01%	524

Other funds holding AGCO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SCS Capital Management's AGCO Position: Q2 2026 in Review

SCS Capital Management held its AGCO (AGCO) position steady in Q2 2026 at 2,000 shares worth $239K. The position accounts for ﹤0.01% of the portfolio, ranked #447.

SCS Capital Management first reported a position in AGCO in Q2 2025 and has held it in 5 quarters since. 517 funds tracked by Wall St. Rank hold AGCO as of Q2 2026.

SCS Capital Management held 2,000 shares of AGCO worth $239K as of Q2 2026.
SCS Capital Management left its AGCO share count unchanged in Q2 2026.
AGCO made up ﹤0.01% of SCS Capital Management's portfolio in Q2 2026, its #447 holding.
SCS Capital Management first reported a position in AGCO in Q2 2025 and has held it in 5 quarters since.
517 funds tracked by Wall St. Rank held AGCO as of Q2 2026.

Based on SCS Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.